Continuous Discovery

Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

Silicon Valley

Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

The Shift Stanford’s AI research group has deployed a 37,000-agent virtual biotech corporation, scaling beyond single-model copilots into orchestrated, division-level workforce simulations. The system’s AI-designed nanobody candidates achieved independent validation by Merck, proving that distributed agent collaboration can outperform monolithic models in complex